Physician profile
Pallavi Reddy
NPI 1164798724
$3,051.42
in general payments reported to CMS, 2019-2025
24 companies · $1,684 in 2025
The $1,684 reported for 2025 was more than what 79% of Sleep Medicine (Family Medicine) providers received nationally (typical 2025 total: $557).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $201 · 2021: $114 · 2022: $125 · 2023: $264 · 2024: $430 · 2025: $1,684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,167 · Education: $190 · Travel and Lodging: $21.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,167.46 |
| Education | $189.98 |
| Travel and Lodging | $21.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $557.67 | 2019-2024 | Inspire |
| Novo Nordisk INC | $369.85 | 2019-2024 | Wegovy |
| Jazz Pharmaceuticals INC. | $269.42 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $252.58 | 2025 | Fasenra, Airsupra, Breztri |
| Resmed Corp | $194.74 | 2023-2025 | |
| Verona Pharma, INC. | $188.85 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $155.17 | 2025 | Zepbound |
| Abbvie INC. | $137.48 | 2024-2025 | |
| Harmony Biosciences LLC | $133.86 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $120.05 | 2025 | Dupixent |
| Genzyme Corporation | $115.22 | 2025 | |
| Avadel Cns Pharmaceuticals, LLC | $80.27 | 2025 | Lumryz |
| Insmed, INC. | $76.14 | 2025 | Brinsupri, Arikayce |
| United Therapeutics Corporation | $67.60 | 2025 | Tyvaso |
| Philips North America LLC | $55.21 | 2025 | Vest Therapy Und |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $48.31 | 2025 | Yupelri |
| Electromed, INC. | $45.28 | 2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $38.14 | 2025 | Glassia |
| Axsome Therapeutics, INC. | $28.06 | 2024 | Sunosi |
| Fisher & Paykel Healthcare INC | $27.45 | 2024 | Fisher & Paykel Healthcare |
| Ani Pharmaceuticals, INC. | $26.90 | 2025 | Purified Cortrophin Gel |
| Vifor Pharma, INC. | $25.01 | 2025 | Zemaira |
| Novartis Pharmaceuticals Corporation | $20.99 | 2025 | |
| Baxter Healthcare | $17.17 | 2025 | Hillrom - Vest System Model 105 Home Care |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pallavi Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.